Eye-tracking is a valuable research tool that is used in laboratory and limited field environments. We take steps toward developing methods that enable widespread adoption of eye-tracking and its real-time application in clinical decision support. Eye-tracking will enhance awareness and enable intelligent views, more precise alerts, and other forms of decision support in the Electronic Medical Record (EMR). We evaluated a low-cost eye-tracking device and found the device’s accuracy to be non-inferior to a more expensive device.
The FDA and EPA have identified pharmacogenomics and toxicogenomics as key opportunities for personalized medicine and environmental risk assessment. The first decade in the 21st century has witnessed breakthroughs in molecular diagnosis and prognosis in cancer treatment. It has now become increasingly important to transform environmental health protection by using high throughput assays to identify genomic biomarkers for personalized risk assessment. This talk will introduce two projects in Dr.